← Back to Search

Cannabis Awareness and Prevention Toolkit for Reducing Youth Cannabis Use

N/A
Waitlist Available
Led By Bonnie Halpern-Felsher, Ph.D.
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to follow-up at approximately 156 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a free online toolkit to educate youth on cannabis use and help reduce use among them.

Who is the study for?
This trial is for middle school and high school students who are currently receiving health education at schools that have chosen to participate in the study. There are no specific exclusion criteria, so all students in these settings can potentially join.
What is being tested?
The trial is testing the Stanford Cannabis Awareness and Prevention curriculum, which is an online resource aimed at increasing knowledge about cannabis and preventing its use among youth. The study will measure if this toolkit changes student attitudes towards using cannabis and their actual usage.
What are the potential side effects?
Since this intervention involves educational material rather than a medical treatment, traditional physical side effects are not applicable. However, there may be psychological impacts from increased awareness or anxiety about cannabis use.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to follow-up at approximately 156 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to follow-up at approximately 156 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in cannabis use
Change in intention to use cannabis in the future

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Receives the Stanford Cannabis Prevention and Awareness curriculumExperimental Treatment1 Intervention
Stanford Cannabis Prevention and Awareness curriculum administered
Group II: Does not receive Stanford Cannabis Prevention and Awareness curriculumActive Control1 Intervention
Receives another curriculum or no cannabis prevention curriculum

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,471 Previous Clinical Trials
17,501,398 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,586 Previous Clinical Trials
3,327,930 Total Patients Enrolled
33 Trials studying Cannabis Use
6,796 Patients Enrolled for Cannabis Use
Bonnie Halpern-Felsher, Ph.D.Principal InvestigatorStanford University
1 Previous Clinical Trials
10,800 Total Patients Enrolled

Media Library

Stanford Cannabis Awareness and Prevention curriculum Clinical Trial Eligibility Overview. Trial Name: NCT05521321 — N/A
Cannabis Use Research Study Groups: Receives the Stanford Cannabis Prevention and Awareness curriculum, Does not receive Stanford Cannabis Prevention and Awareness curriculum
Cannabis Use Clinical Trial 2023: Stanford Cannabis Awareness and Prevention curriculum Highlights & Side Effects. Trial Name: NCT05521321 — N/A
Stanford Cannabis Awareness and Prevention curriculum 2023 Treatment Timeline for Medical Study. Trial Name: NCT05521321 — N/A
~0 spots leftby Nov 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top